234 related articles for article (PubMed ID: 33822327)
1. Efficacy and safety of radiofrequency ablation in the treatment of low-risk papillary thyroid carcinoma: a review.
Ntelis S; Linos D
Hormones (Athens); 2021 Jun; 20(2):269-277. PubMed ID: 33822327
[TBL] [Abstract][Full Text] [Related]
2. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
Chung SR; Baek JH; Choi YJ; Lee JH
Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
4. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis.
Tang W; Tang X; Jiang D; Zhang X; Wang R; Niu X; Zang Y; Zhang M; Wang X; Zhao C
Front Endocrinol (Lausanne); 2022; 13():967044. PubMed ID: 36072932
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study.
Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J
Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861
[TBL] [Abstract][Full Text] [Related]
7. Rigorous radiofrequency ablation can completely treat low-risk small papillary thyroid carcinoma without affecting subsequent surgical management.
Li X; Li J; Qiao Z; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Eur Radiol; 2023 Jun; 33(6):4189-4197. PubMed ID: 36538070
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study.
Zhang M; Luo Y; Zhang Y; Tang J
Thyroid; 2016 Nov; 26(11):1581-1587. PubMed ID: 27445090
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
10. One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: The first experience in Taiwan.
Lim LS; Lin WC; Chiang PL; Huang SC; Chen YS; Chang YH; Chen WC; Chi SY; Chou CK
J Formos Med Assoc; 2022 Aug; 121(8):1406-1413. PubMed ID: 34657768
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients.
Yan L; Lan Y; Xiao J; Lin L; Jiang B; Luo Y
Eur Radiol; 2021 Feb; 31(2):685-694. PubMed ID: 32813103
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma.
Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y
JAMA Surg; 2024 Jan; 159(1):51-58. PubMed ID: 37878294
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
Tong M; Wang L; Gai Z; Zhu Y; Che Y
Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-guided Radiofrequency Ablation for Cervical Lymph Nodes Metastasis from Papillary Thyroid Carcinoma.
Guang Y; Luo YK; Zhang Y; Zhang MB; Li N; Zhang Y; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):67-71. PubMed ID: 29532783
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study.
He H; Song Q; Lan Y; Yan L; Xiao J; Zhang Y; Luo Y
Int J Hyperthermia; 2021; 38(1):604-610. PubMed ID: 33853489
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma in the danger triangle area: a preliminary analysis.
Zhang DL; Chen S; Qiu Y; Yang JC; Hong Z; Li J; Wu SS
Int J Hyperthermia; 2024; 41(1):2305256. PubMed ID: 38314684
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Thermal Ablation Techniques for the Treatment of Primary Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis.
Choi Y; Jung SL
Thyroid; 2020 May; 30(5):720-731. PubMed ID: 31801432
[No Abstract] [Full Text] [Related]
19. Ultrasound-Guided Radiofrequency Ablation
He H; Wu R; Zhao J; Song Q; Zhang Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():734432. PubMed ID: 34512557
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Xue J; Teng D; Wang H
Int J Hyperthermia; 2022; 39(1):1300-1309. PubMed ID: 36195326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
